Journal of Indian Society of Periodontology
Journal of Indian Society of Periodontology
Home | About JISP | Search | Accepted articles | Online Early | Current Issue | Archives | Instructions | SubmissionSubscribeLogin 
Users Online: 2544  Home Print this page Email this page Small font size Default font size Increase font sizeWide layoutNarrow layoutFull screen layout


 
   Table of Contents    
REVIEW ARTICLE
Year : 2012  |  Volume : 16  |  Issue : 1  |  Page : 4-10  

Novel and often bizarre strategies in the treatment of periodontal disease


Department of Periodontics, Sri Sai College of Dental Surgery, Vikarabad, Andhra Pradesh, India

Date of Submission15-Sep-2010
Date of Acceptance09-Jan-2011
Date of Web Publication3-Apr-2012

Correspondence Address:
Haritha Avula
Sri Sai College of Dental Surgery, Vikarabad, Andhra Pradesh
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0972-124X.94595

Rights and Permissions
   Abstract 

Treatment of periodontal disease involves complex mechanical, surgical, and medical modalities. Some of the treatment regimens are patient centered, some involve a great amount of technical expertise and competence from a practitioner, and often involve complex procedures like use of tissue-engineered products. In spite of several advances, treatment of periodontal disease depends on scaling and root planing and various surgical procedures as the mainstay, but results of treatment are not always predictable and are often frustrating. The ultimate aim of periodontal treatment is regeneration of periodontal tissues and more particularly lost alveolar bone support. The treatment options include a myriad of approaches and scientists and researchers have tried various tools and agents to improve alveolar bone status and improve periodontal health. These approaches vary from simple monotherapy with systemic antibiotic usage to exotic and novel procedures like shock wave therapy, photodynamic therapy and application.

Keywords: Periodontal disease, treatment, novel methods


How to cite this article:
Kumar A J, Anumala N, Avula H. Novel and often bizarre strategies in the treatment of periodontal disease. J Indian Soc Periodontol 2012;16:4-10

How to cite this URL:
Kumar A J, Anumala N, Avula H. Novel and often bizarre strategies in the treatment of periodontal disease. J Indian Soc Periodontol [serial online] 2012 [cited 2020 Jun 2];16:4-10. Available from: http://www.jisponline.com/text.asp?2012/16/1/4/94595


   Introduction Top


Periodontal disease is chronic, nagging, and requires meticulous attention by the clinician, dental hygienist, and great efforts by the patients in the form of compliance. There are considerable variations in clinical presentations of periodontal disease, which have been spoken as disease activity models. Although plaque/biofilm is the principal causative factor, several other host-related, environmentally altered factors seem to be playing at tandem. Control of plaque by mechanical means and use of antimicrobials locally and systemically have been the principal methods of disease prevention and containment. However, mechanical plaque control is tedium and taxing on the patients resources and not many patients have the inclination or mindset to scrupulously adhere to demanding and exacting oral hygiene practices. Use of antimicrobials has its own limitations in the form of return and recolonization of the organisms once there is cessation of antibiotic use and other issues related to their prolonged use.

Although there are several procedures available for regeneration of alveolar bone, the results are not always consistently observed. Alveolar bone stimulation has always been a fertile area of research in periodontal therapy.

A practical, convenient, and pragmatic way to treat periodontal disease has been the dream of every clinician. However, realization of the dream seems to be elusive. The prime concern in any periodontal treatment is a control over the errant microorganisms and resolution of soft tissue inflammation and restoration of lost alveolar support. Resolution of soft tissue inflammation appears to be an established accomplishment after scaling, root planing (SRP) and oral hygiene instructions. Control of pathogenic microorganisms has met with limited success with local and systemic antibiotics and restoration of lost alveolar bone support has met with equivocal success.

Various treatment options are available in the armory of a periodontist including surgical and non-surgical therapy, regeneration techniques, tissue engineering etc. Not satisfied with traditional weapons to combat oral microbiota and restore lost alveolar bone support, ingenious clinicians, scientists, and researchers have turned toward novel and sometimes exotic avenues and explored new frontiers of physical laws, pharmacological molecules, and borrowed ideas and concepts as available for other medical situations. The newer approaches may be listed as follows:

  1. Extracorporeal shock wave therapy
  2. Photodynamic therapy
  3. Electrical stimulation on osteogenesis of alveolar bone
  4. Ultrasonic vibrations
  5. Biofilms and bioelectric effect
  6. Control of subgingival biofilm with fine grain glycine powder polishing
  7. Hyperbaric oxygen therapy
  8. Topical and systemic administration of simvastatins
  9. Local and systemic use of bisphosphonates
  10. Use of Teriparatide
  11. Use of antibiotics as monotherapy
  12. Replacement therapy, use of probiotics
  13. Use of herbs, fruits, flowers, foods to resolve inflammation and improve regeneration
  14. Gene therapy
  15. Use of stem cells
  16. Nanotechnology
  17. Use of newer molecules to resolve inflammation
  18. Therapeutic approaches recently available to control inflammation and bone resorption.


Extracorporeal shock wave therapy

Satish Kumar [1] and workers hypothesized that extracorporeal shock wave therapy (ECSWT) could promote alveolar bone regeneration in experimentally created periodontitis in rats. The methodology involved an episode of 100, 300, or 1000 impulses of shock on both cheeks at energy levels of 0.1 mJ/ mm 2 . A follow-up up to 12 weeks showed improved alveolar bone levels in ECSWT treated rats compared with those which did not receive the shock wave therapy. The authors concluded that ECSWT could be evaluated as an adjunct in periodontal therapy.

Extra shock waves are high frequency energy waves generated under water with high voltage explosion and vaporization. ESWT has been successfully used in various medical disorders like disintegration of kidney stones, healing of non-healing fractures, tendinitis etc. The exact mechanism of action of ESWT is not understood, but it is believed to stimulate angiogenesis related growth factors, factors and proliferation and proliferation cell molecular antigen. The sum effect is improved vascularization, tissue regeneration, and repair. This paper is the first of its kind, where ESWT is applied in the periodontal field. ESWT has been shown to have bactericidal effect on several microorganisms including A. aureus, S. epidermidis, Pseudomonas aerogenosa, and methicillin resistant streptococcus aureus strains. [2],[3],[4]

Photodynamic therapy

Medical applications of photodynamic therapy (PDT) include treatment of cancer, psoriasis, actinic keratosis, rheumatoid arthritis, age related macular degeneration. Broadly, it represents an alternative antibacterial, antifungal, and antiviral approach for drug-resistant organisms including bacteria that grow in the biofilm. Photosensitizers are activated by red light between 630 and 700 nm corresponding to a light penetration depth from 0.5 cm (at 630 nm) to 1.5 cm at (700 nm) which is sufficient for periodontal treatment. Sources of this light include a range of lasers, and at present, diode lasers are used predominantly. Non-laser light sources like light emitting diode (LED) and light cure units have been tried. An ideal photosensitizer should be non-toxic, should display local toxicity only after activation by illumination. Most commonly used phtosensitizers include phenothiazine dyes, methelyene blue, and toluidine blue. PDT resulted in improved clinical parameters and decrease in Tumor necrosis factor-α (TNF) and the ligand for receptor activator of NF-κB (RANKL) levels when used as a monotherapy in aggressive periodontitis compared with SRP. [5] In a randomized, controlled study, patients with chronic periodontitis showed improvement in clinical outcomes when PDT was employed as an adjunct to conventional subgingival debridement. [6]

Electrical stimulation on osteogenesis of alveolar bone

An excellent review of the subject was given by Kuboto [7] and workers in 1995. Electromagentic fields (EMF) have been extensively tried in non-union of fractures, artificial bone defects, regeneration of partial limb etc. Karaki et al., [8] studied electrical stimulation in periodontal regeneration by applying tissue expanding mesh in artificially created horizontal bone defects in dogs. Callus formation was better in defects treated with mesh compared with contra lateral untreated controls. EMF induced increased osteogenesis was suggested as an attractive method for enhanced alveolar regeneration. Alveolar bone defects treated with guided tissue regeneration (GTR) enhanced EMF showed better results compared with controls. [9] Biphasic direct current has been found to contribute to enhanced osteogenesis, and could be applied clinically to the early bone formation around implants. [10] Electromotive forces used alone or in conjunction with graft material or guided tissue regeneration may lead to a new dimension in periodontal therapy in future. [11] Clinical non-invasiveness of EMF and its widespread applications in orthopedic fields makes it an ideal tool for further research in periodontics.

Use of ultrasonics to control biofilm

Recent research has shown that application of antibiotics/antimicrobials coupled with low power ultrasound, significantly aids in controlling bacteria. Most of the work is done by workers from Brigham Young University, Utah, [12] whose research has demonstrated the bactericidal effect of low frequency ultrasonic waves when combined with antibiotics in both planktonic and biofilm forms. The action of ultrasonics in enhancing antibiotic action is not clear but may be due to perturbation of cell membrane or stress response by the bacteria. Research on ultrasonic applications with antimicrobials on oral biofilms is, however, not yet a fertile field of research although oral biofilm and the consequences there off are of greater significance than many other parts of the body. Probably, the initial equivocal results with ultrasonic applications and paradigm shifts in treatment on tissue engineered outcomes has cooled off the attention and the initial enthusiasm.

Biofilms and the bioelectric effect

Blenkinsopp [13] and workers in 1992 first reported the use of electric fields to enhance the efficacy of antibiotics in killing bacterial biofilms. The research opened up many possibilities, especially when it was also reported that antibiotic concentrations were lower and very low current densities were needed. Most of the subsequent research focused on prevention and treatment of device-related bacterial infections. [16]

Control of subgingival biofilm with fine grain glycine powder polishing

An innovative approach in the control of subgingival biofilm was recently introduced in the form of glycine powder polishing. Several beneficial effects have been attributed to glycine which is an amino acid. The polishing requires a special apparatus and controlled pressure. Supragingivally applied glycine powder air polishing (supra-GPAP) has been shown to remove biofilms in shallow periodontal pockets. A recent randomized controlled trial (RCT) has concluded that sub-GPAP is more efficacious in removing subgingival biofilms in moderate to deep periodontal pockets than SRP. [14]

Use of hyperbaric oxygen therapy

Hyperbaric oxygen therapy (HBOT), also known as hyperbaric medicine, is the medical use of O 2 at higher than atmospheric pressure. HBOT is a mode of therapy when patient breathes 100% oxygen intermittently.

Most of the studies are interestingly by Chinese researchers. Chen [15],[16] studied the effect of hyperbaric oxygen alone, hyperbaric oxygen with SRP, SRP alone, and controls. Clinical parameters, gingival blood flow, and microbiologic assessment were done. Of particular relevance was the effect on anaerobic organisms. HBOT has a detrimental effect on anaerobes. Significant differences were observed in clincial indices, gingival blood flow, subgingival anaerobe number, number of rods, curved rods, fusiform bacteria, and spirochetes by comparison of hyperbaric oxygen+scaling and scaling alone groups. The authors concluded that hyperbaric oxygen had beneficial therapeutic effects on severe periodontitis, which could last more than one year. Alexander et al., [17] used adjunctive O 2 therapy to accelerate clinical improvement in patients with acute nercotizing ulcerative gingivitis (ANUG). O 2 therapy seemed to result in rapid clinical improvement with less periodontal destruction.

HBOT is expensive; units are not available for routine use and should be used with caution in view of several general systemic conditions which contraindicate its use. There are some risks associated with indiscriminate use of HBOT. Barotrauma, effect on lungs and ear drums, O 2 toxicity, and effect on lens with blurred vision are reported. It should also be used with caution in patients with respiratory infections, high fever, history of thoracic surgery, and emphysema. The possible beneficial effects should be weighed against practical logistics in clinical practice.

Use of statins

Hydroxymethylglutaryl-coenzyme A reductase inhibitors, commonly called as statins, have also been studied with reference to their ability to induce alveolar bone regeneration. Simvastatin was injected into buccal mucosa, and micro computed tomography and histological examination was carried out. Simvastatin increased and maintained a high level of osteoblastic function. It was concluded that topical Simvastatin can stimulate osteoblastic activity and be used topically to reverse the alveolar bone loss in rats. [18]

Recently, using a novel Periodontal inflammatory burden index, it was reported that statin users exhibited fewer periodontal inflammatory injuries and the beneficial effect was attributed to their pleiotropic anti-inflammatory effect. [19] Simvastatin was found to reduce NF-Kappa B and AP-1 promoter activity in KB cells and result in an anti-inflammatory effect on human oral epithelial cells involving Rac1 GTPase inhibition. [20] In a randomized clinical trial, Pradeep and Thorat [21] administered 1.2 mg of simvastatin gel as an adjunct to SRP in patients with chronic periodontitis, and after 6 months, reported promising improvements in gingival inflammation, probing depth, and intrabony defect fill.

Use of bisphosphonates

Bisphosphonates are commonly used for prevention and treatment of osteoporosis, Paget's disease, hypercalcemia associated with malignancy, and osteolysis associated with metastatic bone disease. Mode of action of bisphosphonates is not clear but seems to inhibit osteoclast function, induce their apoptosis, inhibit differentiation of bone marrow precursor cells into osteoclasts. Most of the studies of bisphosphonates are done in animals. In a human study, [22],[23] 70 mg of alendronate was administered once weekly for two years. No adverse effects were observed, but the study did not show any detectable effect on alveolar bone loss except in patients with low mandibular bone mineral density.

In another clinical study, [24] one tablet of Fosamax (alendronate sodium) was administered every morning for six months in patients with periodontitis. Bone density was significantly more in the alendronate group compared to controls. It had no impact on clinical parameters and the authors suggested that bisphosphonates could play an important role in management of periodontal disease. Lane, [25] in a clinical study, used bisphosphonate for one year and could not find any improvement in bone level. Bisphosphonate with low doses of doxycycline was found to provide beneficial effects in periodontal therapy. [26],[27],[28]

Use of teriparatide

Teriparatide is a drug composed of first 34 amino acids of parathromone hormone, and has been known to have anabolic effects on bone and found to be useful in the treatment of osteoporosis and treatment of fractures. Bashutski and workers [29] tested the role of teriparatide in human periodontal defects. Forty patients were treated with periodontal surgery followed by daily injections teriparatide (20 μg) or placebo, along with oral calcium (1000 mg) and vitamin D (800 IU) supplementation, for six weeks. Teriparatide, as compared with placebo, was associated with improved clinical outcomes, greater resolution of alveolar bone defects, and accelerated osseous wound healing in the oral cavity The study subjects need to be complimented for their perseverance to take daily injections for six weeks continuously and such therapy may not be always be practical.

Use of systemic antibiotics as mono-therapy

Lopez et al., [30] in 2006 reported an unusual and unconventional approach to treat chronic periodontitis in previously untreated patients. The author's surmise was that many periodontal patients do not have access to state-of-the-art periodontal therapy. This is particularly relevant in underdeveloped countries, which are hampered by poor dental health infrastructure. Their study involved administering a course of amoxycillin and metronidazole only to one group and SRP only in another group. Similar beneficial results were observed in both the groups, indicating the effectiveness of antibiotic monotherapy.

Single use of amoxicillin+metronidazole, if the reports are to be believed, would in most instances control periodontal disease and if needed the antibiotics can be replenished periodically. If a life term untreated disease burden was improving with single course of antibiotics, few more courses of such protocol would be a better option than the taxing and exacting non-surgical mechanical periodontal therapy. The topic did raise several eyebrows and an academic storm in the tea cup. Such approach has been labeled as 'heresy' and the methodology and conclusions have been questioned. [31],[32] However, the authors did break convention and dogma and tried to free patients from the shackles of a tortuous and exacting demands of non-surgical mechanical periodontal therapy.

Replacement therapy

Applying beneficial bacteria subgingivally so that they will prevent pathogenic organisms recolonizing after SRP was pioneered by Teughels. [33]

Shimauchi, [34] et al. tested the effect of intake of three tablets daily consisting of freeze dried streptococcus salivarius for eight weeks. Salivary lactoferrin levels and lactobacilli in plaque and saliva were assessed at the end of experimental intervention and compared with those who received only placebo. It was concluded that 'probiotics could be useful in improvement/maintenance of oral health in subjects at a high risk of periodontal disease.

Foods, flowers, and seeds

Trying an extract of licorice (Glycyrrhiza uralensis), Bodet [35] concluded that licorice extract could be a potent inhibitor of proinflammatory response and could be a potential candidate to prevent and/or treat periodontitis-associated tissue destruction. Eucalyptus extract chewing gum used for 12 weeks had a significant effect on clinical parameters and was claimed to promote periodontal health. [36] Reporting the results of miswak pieces on aggregatibacter actinomycetecomitans and porphyromonas gingivalis, Sofrata [37] concluded that miswak pieces had an antibacterial effect and the effect was due to the presence of volatile active antibacterial compounds.

Testing the association between intake of dietary products and periodontal disease, Shimazaki [38] reported that with daily intake of milk, cheese, lactic acid containing foods (yogurt and lactic acid drinks) may be beneficial for periodontal health. A similar inverse association between intake of dairy products and prevalence of periodontal disease was observed by Al-Zahrani. [39] The role of melatonin has been reviewed by Cutando, [40] who concluded that it may play a role as an antioxidant and immunoregulatory agent and contribute to regeneration of alveolar bone through stimulating type1 collagen production and influence osteoblastic and osteoclastic activity. Anti-inflammatory effect of elder flower (Sambus Nigra) has been studied and it has been suggested as a therapeutic measure to control periodontal inflammation. [41]

Proanthocyanidines from grape fruit seed has potential antioxidant properties and could be considered a potential agent in preventing periodontal disease. [42] The ability of Triphala, an Indian Ayurvedic drug to inhibit the effect of matrix metalloproteinase (MMP)-9 was tested by Abhram and workers, [43] who concluded that it had a strong inhibitory effect on the extracellular matrix degradation during periodontitis. An interesting study assessing the impact of green tea intake and periodontal disease indicated a modest inverse association. [44] Monthly tomato intake seems to have positive relationship in periodontal patients, [45] and systemic administration of lycopene in conjunction with routine scaling has been associated with positive effect on gingivitis. [46] Cranberry juice constituents, Co-enzyme Q, honey, propolis, tea tree oil, dietary fatty acid, and fish oil supplementation have been used in various forms to control gingivitis or moderate periodontal disease. [47],[48],[49],[50],[51],[52],[53]

Gene therapy in periodontics

Gene therapeutics - periodontal vaccination: Plasmid DNA encoding Porphyromonas gingivalis fimbrial gene resulted in production of several salivary and serum antibodies in mouse. Immunoglobulin thus secreted could neutralize P. gingivalis and limit its pathogenic ability. Immunization with genetically engineered s.gordoni vector expressing P gingivalis fimbrial antigen acted as a vaccine against P gingivalis induced periodontitis in rats. [54] Recombinant hemagglutinin, which is an important virulence factor of P gingivalis, when injected into rats, gave protection against P gingivalis induced bone loss. [55]

Genetic approach and biofilm antibiotic resistance

It is of common knowledge that biofilm bacteria show great resistance to antibiotics. Gene ndvB, which protects a wild form of Pseudomonas aeuroginosa strain, has been rendered ineffective by isolation of a ndvB mutant strain, which makes it susceptible to antibiotic therapy. [56]

Remodeling following gene transfer by electroporation

Alveolar remodeling can occur with various types of stimuli. Application of electric impulse (electroporation) is one such stimuli mediated through a gene transfer. Using in vivo transfer of Lac Z gene (gene encoding for various remodeling molecules) into periodontium and using plasmid as a vector, Tsuchiya et al., [57] reported predictable alveolar bone remodeling.

Tight adherence gene to control periodontal disease progression

Tight adherence gene (TAG) is essential for adherence and virulence of Actinobacillus actinomycetemcomitans. Mutant strains lacking TAG and the consequent lack of aggressiveness have been developed. [58] Such mutant strains could minimize colonization of actinobacillus actinomycetemcomitans and control/alter periodontal disease progression.

Antimicrobial gene therapy

Host defense can be enhanced by transfecting host cells with an antimicrobial peptide/protein - encoding gene. Host cells infected with β defensin-2 (HBD-2) gene via retroviral vector showed enhanced antimicrobial activity and improved host defense. [59]

Use of antagonists to TNF α and similar other substances to contain progression of disease

Research on these lines i.e. to suppress inflammatory and harmful substances by gene delivery is being attempted. The process is complicated and still in the animal model stage only. All the gene transfer research is in its infancy and tangible clinical results are yet to unfold.

Stem cells, tissue engineering, and proteomics

Stem cells, tissue engineering, and proteomics have made great inroads into therapeutic approaches of several systemic diseases, and periodontics is no exception to this phenomenon. With the increasing focus on mesenchymal stem cells in the periodontium, stem cell based therapies are not far from being launched. Periodontal ligament stem cells transplanted into immune compromised mice differentiated into cementoblast-like cells, adipocytes and collagen forming cells, and it was suggested that periodontal ligament (PDL) stem cells have the potential to generate cementum/PDL like tissue in vivo. [60]

Nanotechnology and periodontal therapeutics

Nano materials are currently being investigated for novel drug delivery and tissue engineering. Local targeted delivery has been enhanced by use of nanosensors, nanoswitches, and other nano delivery systems. Triclosan nano particles were able to reduce gingival inflammation. [61] Arestin is one such example where tetracycline incorporated into microspheres and has shown promising results when locally delivered into periodontal pockets.

Use of newer molecules to resolve inflammation like resolvins

Resolvins (resolution - phase interaction products) are endogenous mediators that have an anti-inflammatory role. They have been found to be effective in preclinical models of asthma, atherosclerosis, rheumatoid arthritis, inflammatory bowel disease, retinal disease etc. They offer an entirely novel biological approach in treatment of several inflammatory diseases.

They reduce neutrophil trafficking, regulate production of cytokines and reactive oxygen species and have been successfully evaluated in ligature induced P gingivalis provoked animal model periodontitis. Prior application of Resolvin E1 prevented animal models from developing periodontitis in contrast to unprotected animals which showed progressive disease. In a recent presentation, [62],[63] it was reported that 'local application of RvE1 (Resolvin E1) in small amounts resulted in complete resolution of inflammation and regeneration of bone'. Although still in a testing stage, the role of resolvins seems to be promising and exciting in periodontal armory.

Recent therapeutic approaches available to control inflammation/bone resorption

Recently several medications targeted to suppress inflammation and bone resorption have been evolved and some of these are primarily directed at control of osteoporosis and rheumatoid arthritis. They include TNF-α inhibitors (Adalimumab, Etanaracept, Golimumab, and Infliximab), anti-cytokine agents (Anakinra, Tocilizumab, and AMG714) and inhibitor of RANK/RANKL (Denosumab). The use of some of these agents has been restricted to animal studies where protective effect on experimentally induced periodontitis lesions was observed. Some of them are available for use in treatment of inflammatory diseases like rheumatoid arthritis, but their applications in periodontal disease are yet to take off and the days are not far off.


   Conclusion Top


Man is an optimist, and in an attempt to gain an upper hand over periodontal destruction, he has tried various indigenous and sometimes disarmingly simple sources. He has tried heat, light, sound, fruits, flowers, herbs, and as a last resort cells and genes. Good supragingival plaque control in combination with mechanical instrumentation and supportive periodontal therapy can maintain periodontal health for more than 20 years [64] and this can be considered as 'gold standard 'of periodontal care. [38] Alternative approaches to this gold standard should be easy to use, affordable, patient friendly, and accessible to large mass of people spread over countries and continents.

 
   References Top

1.Sathish Kumar S, Meka A, Dawson D, House N, Schaden W, Novak MJ, et al. Extracorporeal shock wave therapy induces alveolar bone regeneration. J Dent Res 2008;87:687-91.  Back to cited text no. 1
    
2.Von Eiff C, Overbeck J, Haupt G, Herrmann M, Winckler S, Richter KD, et al. Bactericidal effect of extracorporeal shock waves on Staphylococcus aureus. J Med Microbiol 2000;49:709-12.  Back to cited text no. 2
[PUBMED]  [FULLTEXT]  
3.Gollwitzer H, Horn C, Von Eiff C, Henne M, Gerdesmeyer L. Antibacterial effectiveness of high-energetic extracorporeal shock waves: An in vitro verification. Z Orthop Ihre Grenzgeb 2004;142:462-6. (Article in German).  Back to cited text no. 3
    
4.Gerdesmeyer L, von Eiff C, Horn C, Henne M, Roessner M, Diehl P, et al. Antibacterial effects of extracorporeal shock waves. Ultrasound Med Biol 2005;31:115-9.  Back to cited text no. 4
[PUBMED]  [FULLTEXT]  
5.De Oliveira RR, Schwartz-Filho HO, Novaes AB Jr, Taba M Jr. Antimicrobial photodynamic therapy in the non-surgical treatment of aggressive periodontitis: A preliminary randomized controlled clinical study. J Periodontol 2007;78:965-73.  Back to cited text no. 5
[PUBMED]  [FULLTEXT]  
6.Braun A, Dehn C, Krause F, Jepsen S. Short-term clinical effects of adjunctive antimicrobial photodynamic therapy in periodontal treatment: A randomized clinical trial. J Clin Periodontol 2008;35:877-84.  Back to cited text no. 6
[PUBMED]  [FULLTEXT]  
7.Kubota K, Yoshimura N, Yokota M, Fitzsimmons RJ, Wikesjö ME. Overview of effects of electrical stimulation on osteogenesis and alveolar bone. J Periodontol 1995;66:2-6.  Back to cited text no. 7
    
8.Karaki R, Kubota K, Hitaka M, Yamaji S, Kataoka R, Yamamoto H. Effect of gum-expanding mesh on the osteogenesis in surgical bony defect. Nippon Shishubyo Gakkai Kaishi 1984;26:516-22.  Back to cited text no. 8
[PUBMED]    
9.Yoshimura N. Effects of electrical stimulation on periodontal tissue regeneration. Application of biodegradable membrane in GTR method. J Kyushu Dent Soc 1993;47:590-606.  Back to cited text no. 9
    
10.Hwang SJ, Song JK, Cho TH, Song, YM, Lee TH, Choung SM,et al. Enhanced bone formation around dental implant using electrical stimulation. Bioengineering Conference 2007;33:11-2.  Back to cited text no. 10
    
11.Kaynak D, Meffert R, Günhan M, Günhan O. A histopathologic investigation on the effects of electrical stimulation on periodontal tissue regeneration in experimental bony defects in dogs. J Periodontol 2005;76:2194-204.  Back to cited text no. 11
    
12.Andrea M, Beverly L, Maren K, Jared L, Rachel L, David O, et al. Ultrasonic enhancement of antibiotic action on Escherichia coli biofilms: An in-vivo model. Antimicrobial Agents and Chemotherapy 1993;43:1211-4.  Back to cited text no. 12
    
13.Blenkinsopp SA, Khoury AE, Costerton JW. Electrical enhancement of biocide efficacy against Pseudomonas aeruginosa biofilms. Appl Environ Microbiol 1992;58:3770-3.  Back to cited text no. 13
[PUBMED]  [FULLTEXT]  
14.Flemmig TF, Arushanov D, Daubert D, Rothen M, Mueller G, LerouxBG. Randomized controlled trial assessing efficacy and safety of glycine powder air polishing in moderate to deep periodontal pockets. J Periodontol 2012;83:444-52.  Back to cited text no. 14
    
15.Chen TL, Lin SL, Liu GQ, Liu JC, Song PZ, Xu B, et al. Effects and holding time of hyperbaric oxygen on human severe periodontitis. Shanghai Kou Qiang Yi Xue 2003;12:403-5.  Back to cited text no. 15
[PUBMED]    
16.Chen T, Zhou Y, Liu J, Xu B, Wu Z, Li D. Biological effects of hyperbaric oxygen on human severe periodontitis. Undersea Hyperb Med 2002;29:159-66.  Back to cited text no. 16
[PUBMED]    
17.Alexander J, Heribert R, Eveline G, Friedrich M. Local oxygen therapy for treating acute necrotizing periodontal disease in smokers. J Periodontol 2006;77:31-8.  Back to cited text no. 17
    
18.Seto H, Ohba H, Tokunaga K, Hama H, Horibe M, Nagata T. Topical administration of simvastatin recovers alveolar bone loss in rats. J Periodontal Res 2008;43:261-7.  Back to cited text no. 18
[PUBMED]  [FULLTEXT]  
19.Lindy O, Suomalainen K, Mäkelä M, Lindy S. Statin use is associated with fewer periodontal lesions: A retrospective study. BMC Oral Health 2008;8:16.  Back to cited text no. 19
    
20.Sakoda K, Yamamoto M, Negishi Y, Liao JK, Node K, Izumi Y. Simvastatin decreases IL-6 and IL-8 production in epithelial cells. J Dent Res 2006;85:520-3.  Back to cited text no. 20
[PUBMED]  [FULLTEXT]  
21.Pradeep AR, Thorat MS. Clinical effect of subgingivally delivered simvastatin in the treatment of patients with chronic periodontitis: A randomized clinical trial. J Periodontol 2010;81:214-22.  Back to cited text no. 21
[PUBMED]  [FULLTEXT]  
22.Jeffcoat MK, Cizza G, Shih WJ, Genco R, Lombardi A. Efficacy of bisphosphonates for the control of alveolar bone loss in periodontitis. J Int Acad Periodontol 2007;9:70-6.  Back to cited text no. 22
[PUBMED]    
23.Jeffcoat MK. Safety of oral bisphosphonates: Controlled studies on alveolar bone. Int J Oral Maxillofac Implants 2006;21:349-53.  Back to cited text no. 23
[PUBMED]    
24.El-Shinnawi UM, El-Tantawy SI. The effect of alendronate sodium on alveolar bone loss in periodontitis (clinical trial). J Int Acad Periodontol 2003;5:5-10.  Back to cited text no. 24
[PUBMED]    
25.Lane N, Armitage GC, Loomer P, Hsieh S, Majumdar S, Wang HY, et al. Bisphosphonate therapy improves the outcome of conventional periodontal treatment: Results of a 12-month, randomized, placebo-controlled study. J Periodontol 2005;76:1113-22.  Back to cited text no. 25
[PUBMED]  [FULLTEXT]  
26.Buduneli E, Vardar S, Buduneli N, Berdeli AH, Türkoðlu O, Baþkesen A, et al . Effects of combined systemic administration of low-dose doxycycline and alendronate on endotoxin-induced periodontitis in rats. J Periodontol 2004;75:1516-23.  Back to cited text no. 26
    
27.Buduneli E, Buduneli N, Vardar S, Kardeºler L, Atilla G, Lappin D, et al . Systemic low-dose doxycycline and alendronate administration and serum interleukin-1beta, osteocalcin, and C-reactive protein levels in rats. J Periodontol 2005;76:1927-33.  Back to cited text no. 27
    
28.Buduneli E, Vardar-Sengül S, Buduneli N, Atilla G, Wahlgren J, Sorsa T. Matrix metalloproteinases, tissue inhibitor of matrix metalloproteinase-1, and laminin-5 gamma2 chain immunolocalization in gingival tissue of endotoxin-induced periodontitis in rats: Effects of low-dose doxycycline and alendronate. J Periodontol 2007;78:127-34.  Back to cited text no. 28
    
29.Bashutski JD, Eber RM, Kinney JS, Benavides E, Maitra S, Braun TM, et al. Teriparatide and osseous regeneration in the oral cavity. N Engl J Med 2010;363:2396-405.  Back to cited text no. 29
[PUBMED]  [FULLTEXT]  
30.Lopez NJ, Socransky SS, Da Silva, Japlit MR, Haffajee AD. Effects of metronidazole plus amoxicillin as the only therapy on the microbiological and clinical parameters of untreated chronic periodontitis. J Clin Periodontol 2006;33:648-60.  Back to cited text no. 30
    
31.Feres EJ, Silva CM, GIovennatti N, Torres MC, Leao ATT, Sansone C. Treatment of chronic periodontitis with systemic antibiotics only. J Clin Periodontol 2006;33:936-7.  Back to cited text no. 31
    
32.Walter C, Weiger R. Antibiotics as the only therapy of untreated chronic periodontitis: A critical commentary. J Clin Periodontol 2006;33:938-9.  Back to cited text no. 32
[PUBMED]  [FULLTEXT]  
33.Teughels W, Newman MG, Coucke W, Haffajee AD, Van Der Mei HC, Haake SK. Guiding periodontal pocket recolonization: A proof of concept. Dent Res 2007;86:1078-82.  Back to cited text no. 33
    
34.Shimauchi H, Mayanagi G, Nakaya S, Minamibuchi M, Ito Y, Yamaki K, et al. Improvement of periodontal condition by probiotics with Lactobacillus salivarius WB21: A randomized, double-blind, placebo-controlled study. J Clin Periodontol 2008;35:897-905.  Back to cited text no. 34
[PUBMED]  [FULLTEXT]  
35.Bodet C, La VD, Gafner S, Bergeron C, Grenier D. A licorice extract reduces lipopolysaccharide-induced proinflammatory cytokine secretion by macrophages and whole blood. J Periodontol 2008;79:1752-61.  Back to cited text no. 35
[PUBMED]  [FULLTEXT]  
36.Nagata H, Inagaki Y, Tanaka M, Ojima M, Kataoka K, Kuboniwa M, et al. Effect of eucalyptus extract chewing gum on periodontal health: A double-masked, randomized trial. J Periodontol 2008;79:1378-85.  Back to cited text no. 36
[PUBMED]  [FULLTEXT]  
37.Sofrata AH, Claesson RL, Lingström PK, Gustafsson AK. Strong antibacterial effect of miswak against oral microorganisms associated with periodontitis and caries. J Periodontol 2008;79:1474-9.  Back to cited text no. 37
    
38.Shimazaki Y, Shirota T, Uchida K, Yonemoto K, Kiyohara Y, Iida M, et al. Intake of dairy products and periodontal disease: The hisayama study. J Periodontol 2008;79:131-7.  Back to cited text no. 38
[PUBMED]  [FULLTEXT]  
39.Al-Zahrani Mohammad S. Increased intake of dairy products is related to lower periodontitis prevalence. J Periodontol 2006;77:289-94.  Back to cited text no. 39
    
40.Cutando A, Gómez-Moreno G, Arana C, Acuña-Castroviejo D, Reiter RJ. Melatonin: Potential functions in the oral cavity. J Periodontol 2007;78:1094-102.  Back to cited text no. 40
    
41.Harokopakis E, Albzreh MH, Haase EM, Scannapieco FA, Hajishengallis G. Inhibition of proinflammatory activities of major periodontal pathogens by aqueous extracts from elder flower (Sambucus nigra). J Periodontol 2006;77:271-9.  Back to cited text no. 41
[PUBMED]  [FULLTEXT]  
42.Houde V, Grenier D, Chandad F. Protective effects of grape seed proanthocyanidins against oxidative stress induced by lipopolysaccharides of periodontopathogens. J Periodontol 2006;77:1371-9.  Back to cited text no. 42
[PUBMED]  [FULLTEXT]  
43.Abraham S, Kumar MS, Sehgal PK, Nitish S, Jayakumar ND. Evaluation of the inhibitory effect of triphala on PMN-type matrix metalloproteinase (MMP-9). J Periodontol 2005;76:497-502.  Back to cited text no. 43
[PUBMED]  [FULLTEXT]  
44.Kushiyama M, Shimazaki Y, Murakami M, Yamashita Y. Relationship between intake of green tea and periodontal disease. J Periodontol 2009;80:372-7.  Back to cited text no. 44
[PUBMED]  [FULLTEXT]  
45.Wood N, Johnson RB. The relationship between tomato intake and congestive heart failure risk in periodontitis subjects. J Clin Periodontol 2004;31:574-80.  Back to cited text no. 45
[PUBMED]  [FULLTEXT]  
46.Chandra RV, Prabhuji ML, Roopa DA, Ravirajan S, Kishore HC. Efficacy of lycopene in the treatment of gingivitis: A randomised, placebo-controlled clinical trial. Oral Health Prev Dent 2007;5:327-36.  Back to cited text no. 46
[PUBMED]    
47.Weiss EI, Lev-Dor R, Kashamn Y, Goldhar J, Sharon N, Ofek I. Inhibiting interspecies coaggregation of plaque bacteria with a cranberry juice constituent. J Am Dent Assoc 1998;129:1719-23.  Back to cited text no. 47
[PUBMED]  [FULLTEXT]  
48.Watts TL. Coenzyme Q and periodontal treatment: Is there any beneficial effect? Br Dent J 1995;178:209-13.  Back to cited text no. 48
[PUBMED]    
49.English HK, Pack AR, Molan PC. The effects of manuka honey on plaque and gingivitis: A pilot study. J Int Acad Periodontol 2004;6:63-7.  Back to cited text no. 49
[PUBMED]    
50.Gebaraa EC, Pustiglioni AN, de Lima LA, Mayer MP. Propolis extract as an adjuvant to periodontal treatment. Oral Health Prev Dent 2005;1:29-35.  Back to cited text no. 50
    
51.Soukoulis S, Hirsch R. The effects of a tea tree oil-containing gel on plaque and chronic gingivitis. Aust Dent J 2004;49:78-83.  Back to cited text no. 51
[PUBMED]  [FULLTEXT]  
52.Rosenstein ED, Kushner LJ, Kramer N, Kazandjian G. Pilot study of dietary fatty acid supplementation in the treatment of adult periodontitis. Prostaglandins Leukot Essent Fatty Acids 2003;68:213-18.  Back to cited text no. 52
[PUBMED]  [FULLTEXT]  
53.El-Sharkawy H, Aboelsaad N, Eliwa M, Darweesh M, Alshahat M, Kantarci A, et al. Adjunctive treatment of chronic periodontitis with daily dietary supplementation with omega-3 fatty acids and low-dose aspirin. J Periodontol 2010;81:1635-43.  Back to cited text no. 53
[PUBMED]  [FULLTEXT]  
54.Sharma A, Honma K, Evans RT, Hruby DE, Genco RJ. Oral immunization with recombinant Streptococcus gordonii expressing porphyromonas gingivalis FimA domains. Infect Immun 2001;69:2928-34.  Back to cited text no. 54
[PUBMED]  [FULLTEXT]  
55.Katz J, Black KP, Michalek SM. Host responses to recombinant hemagglutinin B of Porphyromonas gingivalis in an experimental rat model. Infect Immun 1999;67:4352-9.  Back to cited text no. 55
[PUBMED]  [FULLTEXT]  
56.Mah TF, Pitts B, Pellock B, Walker GC, Stewart PS, O'Toole GA. A genetic basis for Pseudomonas aeruginosa biofilm antibiotic resistance. Nature 2003;426:306-10.  Back to cited text no. 56
[PUBMED]  [FULLTEXT]  
57.Tsuchiya S, Chiba M, Kishimoto K, Nakamura H, Mitani H. Tohoku University, Sendai. Gene transfer into periodontal tissue by in vivo electroporation. Available from: http://www.Iadr.confex.com [2011 Sep 01].  Back to cited text no. 57
    
58.Schreiner HC, Sinatra K, Kaplan JB, Furgang D, Kachlany SC, Planet PJ, et al. Tight-adherence genes of Actinobacillus actinomycetemcomitans are required for virulence in rat model. Proc Natl Acad Sci U S A 2003;100:7295-300.  Back to cited text no. 58
[PUBMED]  [FULLTEXT]  
59.Huang GT, Zhang HB, Kim D, Liu L, Ganz T. A model for antimicrobial gene therapy: Demonstration of human beta-defensin 2 antimicrobial activities in vivo. Hum Gene Ther 2002;13:2017-25.  Back to cited text no. 59
[PUBMED]  [FULLTEXT]  
60.Seo BM, Miura M, Gronthos S, Bartold PM, Batouli S, Brahim J, et al. Investigation of multipotent postnatal stem cells from human periodontal ligament. Lancet 2004;364:149-55.  Back to cited text no. 60
[PUBMED]  [FULLTEXT]  
61.Pinon SE, Ganem QA, Alonso PV, Quintanar GD. Preparation and characterization of triclosan nanoparticles for periodontal treatment. Int J Pharm 2005;294:217-32.  Back to cited text no. 61
    
62.Hasturk, Kantarci A, Goguet-Surmenian E, van dyke TE, Serhan CN. Resolvin D 1 a novel docosahexaenoic acid-derived mediator resolves experimental periodontitis. American Aacademy of Dental Research, Geneal session, Miami, Florida 1-4 2009 paper No. 2930.  Back to cited text no. 62
    
63.Hasturk H, Kantarci A, Ohira T, Arita M, Ebrahimi N, Chiang N, et al. RvE1 protects from local inflammation and osteoclast- mediated bone destruction in periodontitis. FASEB J 2006;20:401-3.  Back to cited text no. 63
    
64.Axelsson P, Nystrom B, Lindhe J. The long term effect of a plaque control program on tooth mobility, caries and periodontal disease in adults. Results after 30 years of maintenance. J Clin Periodontol 2004;31:749-57.  Back to cited text no. 64
    



This article has been cited by
1 Future prospects of systemic host modulatory agents in periodontal therapy
Gokhale, S.R. and Padhye, A.M.
British Dental Journal. 2013; 214(9): 467-471
[Pubmed]



 

Top
   
 
  Search
 
  
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

 
  In this article
    Abstract
   Introduction
   Conclusion
    References

 Article Access Statistics
    Viewed5205    
    Printed160    
    Emailed0    
    PDF Downloaded1398    
    Comments [Add]    
    Cited by others 1    

Recommend this journal